Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
A research study looking at how oral semaglutide works in people with type 2 diabetes in Denmark, as part of local clinical practice (PIONEER REAL)
The advent of the first generic GLP-1 drugs could help Medicare negotiate a lower price for the highly sought after diabetes and obesity medication semaglutide, according to experts familiar with the price-negotiation program and STATs review of documents from the first round of negotiations
This is highly recommended because our inventory can sell very fast, with some restocks only lasting a few days
The global market for anti-obesity medications is expected to grow by 25% over the next five years, driven largely by demand in North America, according to Medi-Tech Insights, a business research firm
PMID: 35490155
